Bi Mengning, Xie Yu, Yu Xiaoyu, Li Hairui, Pelekos George, Jin Lijian, Li Yuan, Tonetti Maurizio S
Shanghai Perio-Implant Innovation Center, Institute of Integrated Oral, Craniofacial and Sensory Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Division of Periodontology and Implant Dentistry, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
J Clin Periodontol. 2025 Sep;52(9):1276-1287. doi: 10.1111/jcpe.14189. Epub 2025 Jun 3.
The diagnostic performance of active matrix metalloproteinase-8 (aMMP-8) point-of-care oral rinse test (POC-ORT) for periodontitis needs to be improved because of its relatively low sensitivity. This study attempted to identify the clinical features associated with the misclassification of periodontal cases by the test.
This work consisted of two cross-sectional diagnostic accuracy studies involving a representative cohort in Hong Kong, China, and a convenience sample of subjects in Shanghai, China. The outcomes of the aMMP-8 POC-ORT (index test) were compared to the case definitions of the 2017 World Workshop on the classification of periodontal health status (reference test). The analysis reports the diagnostic accuracy parameters, the Youden index and correlations between the aMMP-8 test outcomes and clinical features.
In this study, 384 and 390 subjects were enrolled in Hong Kong and Shanghai, respectively. The conventional 20 ng/mL threshold failed to detect more than 50% of early-stage (I/II) cases. The positive POC-ORT results were significantly correlated with the number of sites with bleeding on probing (BOP), probing pocket depth (PPD) ≥ 4 mm, PPD ≥ 5 mm, PPD ≥ 4 mm and BOP, PPD ≥ 5 mm and BOP and clinical attachment loss. The adjusted odds ratio (OR) for a positive test increased with the number of sites with PPD ≥ 5 mm: 1.092 (95% CI: 1.063-1.127, p < 0.001) for the Hong Kong sample and 1.074 (95% CI: 1.050-1.100, p < 0.001) for the Shanghai sample, suggesting a higher likelihood of a positive result with each additional pocket ≥ 5 mm. The same was observed for PPD ≥ 5 mm with BOP: 1.093 (95% CI: 1.064-1.129, p < 0.001) and 1.077 (95% CI: 1.052-1.105, p < 0.001). Notably, the false-negative cases were characterised by a significantly smaller number of periodontal pockets, BOP percentages and bleeding pockets than the true-positive ones.
The false-negative cases, which are responsible for the observed low sensitivity of the POC-ORT, showed more localised periodontal inflammation and pocketing. As the oral rinse test measures the overall level of aMMP-8 cleared by the gingival crevicular fluid from various lesions throughout the whole dentition, localised periodontitis appears more difficult to detect. Additional studies are needed to optimise the sampling strategy and set the cut-off value of a positive test.
The study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (IRB Approval: UW22-132; trial registration: NCT03928080) and the Shanghai Ninth People's Hospital Ethics Committee (IRB Approval: SH9H-2021-T408-3; trial registration: NCT05513599).
活性基质金属蛋白酶-8(aMMP-8)即时检测口腔冲洗试验(POC-ORT)用于牙周炎的诊断性能因灵敏度相对较低而有待提高。本研究试图确定与该试验对牙周病例误诊相关的临床特征。
这项工作包括两项横断面诊断准确性研究,一项涉及中国香港具有代表性的队列,另一项涉及中国上海的方便样本受试者。将aMMP-8 POC-ORT(指标试验)的结果与2017年牙周健康状况分类世界研讨会的病例定义(参考试验)进行比较。分析报告了诊断准确性参数、约登指数以及aMMP-8试验结果与临床特征之间的相关性。
在本研究中,香港和上海分别招募了384名和390名受试者。传统的20 ng/mL阈值未能检测出超过50%的早期(I/II期)病例。POC-ORT阳性结果与探诊出血(BOP)部位数量、探诊袋深度(PPD)≥4 mm、PPD≥5 mm、PPD≥4 mm且伴有BOP、PPD≥5 mm且伴有BOP以及临床附着丧失显著相关。随着PPD≥5 mm部位数量的增加,试验阳性的调整优势比(OR)升高:香港样本为1.092(95%CI:1.063 - 1.127,p<0.001),上海样本为1.074(95%CI:1.050 - 1.100,p<0.001),这表明每增加一个≥5 mm的牙周袋,阳性结果的可能性更高。PPD≥5 mm且伴有BOP的情况也是如此:分别为1.093(95%CI:1.064 - 1.129,p<0.001)和1.077(95%CI:1.052 - 1.105,p<0.001)。值得注意的是,假阴性病例的牙周袋数量、BOP百分比和出血袋数量明显少于真阳性病例。
导致POC-ORT观察到低灵敏度的假阴性病例表现出更局限的牙周炎症和牙周袋形成。由于口腔冲洗试验测量的是龈沟液从全口牙列各处病变清除的aMMP-8总体水平,局限性牙周炎似乎更难检测到。需要进一步研究以优化采样策略并设定阳性试验的临界值。
本研究获得香港大学/香港西区医院管理局机构审查委员会批准(IRB批准:UW22 - 132;试验注册:NCT03928080)以及上海交通大学医学院附属第九人民医院伦理委员会批准(IRB批准:SH9H - 2021 - T408 - 3;试验注册:NCT05513599)。